Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications.
Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L.
Buqué A, et al. Among authors: tartour e.
Oncoimmunology. 2015 Mar 2;4(4):e1008814. doi: 10.1080/2162402X.2015.1008814. eCollection 2015 Apr.
Oncoimmunology. 2015.
PMID: 26137403
Free PMC article.
Review.